Detalles de la búsqueda
1.
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C.
Liver Int
; 41(8): 1802-1814, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33497016
2.
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
Clin Infect Dis
; 64(5): 680-683, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28011605
3.
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports.
Am J Kidney Dis
; 70(2): 297-300, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28258770
4.
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies.
Liver Int
; 37(4): 514-528, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28105744
5.
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
Emerg Microbes Infect
; 12(1): 2219347, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37288750
6.
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b.
Viruses
; 13(5)2021 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33922732
7.
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection.
Emerg Microbes Infect
; 9(1): 928-939, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32312174
8.
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.
PLoS One
; 13(2): e0192627, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29462201
9.
HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
Viruses
; 10(7)2018 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29987240
10.
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.
Sci Rep
; 8(1): 8988, 2018 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29895871
11.
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
Oncotarget
; 8(9): 15704-15715, 2017 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28152517
12.
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.
PLoS One
; 12(5): e0177352, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28545127
13.
Development of hepatotoxicity in HIV patients switching at least one protease inhibitor.
Int J STD AIDS
; 16(2): 148-52, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15825250
14.
Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression.
Eur J Gastroenterol Hepatol
; 16(9): 891-6, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15316414
15.
Helicobacter pylori active infection in patients with acute coronary heart disease.
J Infect
; 49(1): 8-12, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15194241
16.
Alanine aminotransferase decrease in HIV-hepatitis C virus co-infected patients responding to antiretroviral therapy.
AIDS
; 17(14): 2141-2, 2003 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-14502025
17.
Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients.
Gastroenterology
; 130(4): 1098-106, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16618404
18.
Undetectable phospho-STAT1 in peripheral blood mononuclear cells from patients with chronic hepatitis C who do not respond to interferon-alpha therapy.
Liver Int
; 25(5): 987-93, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16162158
19.
A case report of pityriasis lichenoides in a patient with chronic hepatitis C.
J Infect
; 51(2): E23-5, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16038744
20.
Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection.
J Acquir Immune Defic Syndr
; 29(1): 41-8, 2002 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11782588